The “Missing Peptides” Behind AFib: Humanin + MOTS-c and the Fibrosis Switch

Atrial fibrillation is typically treated like an electrical glitch — rate control, rhythm control, anticoagulation. But this Deep Dive explores a newer frame: AFib may be driven by metabolic collapse and fibrotic remodeling rooted in mitochondrial dysfunction. Dr. Mike breaks down a May 5 Biomedicines paper titled “Humanin and MOTS-c attenuate atrial fibrillation by suppressing fibrosis and mitochondrial dysfunction,” highlighting why mitochondrial-derived peptides (MDPs) — Humanin and MOTS-c — may function as stress-responsive guardians that help preserve mitochondrial integrity, reduce oxidative stress, and blunt fibrosis. You’ll hear the key human tissue findings (both peptides downregulated in AFib atrial appendages), the biomarker signal (plasma MOTS-c inversely tracking NT-proBNP), the “Humanin paradox” (plasma up while atrial tissue down), and the mouse data showing peptide treatment reduced AFib inducibility and structural remodeling. The episode closes with a big question: if heart health is about fueling cellular engines, not just fixing wiring, how does that reshape aging medicine?

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction

-

Key Quotes From Dr. Mike:

“For decades, the medical establishment has approached AFib as an electrical failure…The true culprit may not be the wiring, but rather the power plants.”

“In patients with atrial fibrillation, these protective peptides essentially vanish... The more severe the peptide depletion, the more advanced the structural damage appeared to be.”

“Our study identifies down regulation of Humanin and MOTS-c as a novel feature of human afib that correlates with fibrosis... As Humanin and MOTS-c levels drop, collagen deposition and atrial fibrosis increase.”

“Humanin predominantly influences cell adhesion and immune response pathways, while mots C targets metabolic processes... They effectively attenuated structural remodeling and significantly reduced afib inducibility…”

“These micropeptides are born directly within the mitochondrial DNA... They are exercise sensitive myokines, meaning physical activity naturally stimulates their production.”

-

Key Points

• The featured paper (May 5, Biomedicines): Humanin + MOTS-c attenuate AFib by suppressing fibrosis and mitochondrial dysfunction.
• AFib is framed as a growing societal burden and a driver of stroke/heart failure; current therapies mainly manage the “wiring.”
• Humanin + MOTS-c are mitochondrial-derived peptides encoded in mtDNA, acting as cytoprotective stress messengers.
• AFib atrial tissue shows significant downregulation of both peptides (spatial transcriptomics + histology).
• Severity link: more depletion → more structural damage/fibrosis.
• Biomarker link: plasma MOTS-c is decreased and inversely correlates with NT-proBNP.
• The “Humanin paradox”: Humanin depleted in atrial tissue but slightly elevated in plasma — blood levels can mislead.
• In a mouse model, HNG (Humanin analog) + MOTS-c reduced AFib inducibility and structural remodeling.
• Mechanistic themes: preserved mitochondrial ultrastructure, normalized fission dynamics, reduced hypertrophy, lowered IL-1β and IL-6.
• Dual-pronged fibroblast control: Humanin influences adhesion/immune pathways, MOTS-c targets metabolic pathways.

-

Episode timeline

• 0:00–0:57 — Intro: peptide-focused season; “future of mitochondrial medicine”
• 0:57–2:32 — Paper setup + personal relevance; why AFib is a mitochondria-dense tissue problem
• 2:32–3:50 — Reframing AFib: from electrical “wiring” to mitochondrial “power plants” + micropharmacology
• 3:50–4:56 — Humanin + MOTS-c basics: mtDNA-encoded “guardians,” exercise-sensitive signaling
• 4:56–6:51 — Human atrial tissue findings: downregulation, severity correlation, MOTS-c vs NT-proBNP
• 6:51–7:56 — Fibrosis link + RAAS context; peptides as complementary anti-scarring pathway
• 7:56–9:47 — Mouse model: HNG + MOTS-c outcomes (ultrastructure, fission, hypertrophy, cytokines)
• 9:47–11:15 — The Humanin paradox: plasma vs tissue concentration; biomarker caution
• 11:15–12:20 — Fibroblast behavior + RNA-seq: Humanin vs MOTS-c “two angles”
• 12:20–13:26 — Synthesis + limitations + closing question (“fueling the cell” paradigm)

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs:

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook